Продажи Изменить Дата
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Almirall EUR 602.71M 55.09M 2026-06
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 120.88M 26.41M 2026-06
Astellas Pharma JPY 629.95B 10.96B 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Charles River Laboratories USD 982.7M 17.3M 2026-09
Coherus Biosciences USD 12.75M 1.18M 2025-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
Incyte USD 1.56B 110M 2026-09
Ironwood Pharmaceuticals USD 113.04M 6.53M 2026-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
MacroGenics USD 32.83M 12.03M 2026-06
Moderna USD 1.31M 98.69M 2026-09
Myriad Genetics USD 190.7M 9.7M 2026-06
PTC Therapeutics USD 357.8M 3.2M 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Takeda JPY 1.19T 32.9B 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12